Oxymetazoline (Sinustop Paediatric Nasal Metered, Sinustop Paediatric Nasal, Nazene Paediatric Nasal Metered, Nazene Paediatric Nasal, Nazene Adult Nasal Metered, Nazene Adult Nasal, Allergex Eye, Sinustop Nasal)
Oxymetazoline
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Certificate holder
- Adcock ingram limited
- Registrations
- 8
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sinustop paediatric nasal metered spray | 1 mlPaediatric nasal metered spray | 390199A39/16.1/0199Approved 28 September 2021 | Registered | Not determined | PIPIL |
| Sinustop paediatric nasal drops EACH 1,0 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,250 mg | Drops | A390198A39/16.1/0198 | Registered | Not determined | None |
| Nazene paediatric nasal metered spray EACH 1,0 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,250 mg | Spray | A390200A39/16.1/0200 | Registered | Not determined | None |
| Nazene paediatric nasal drops EACH 1,0 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,250 mg | Drops | A390201A39/16.1/0201 | Cancelled | Not determined | None |
| Nazene adult nasal metered spray EACH 1,0 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,50 mg | 1 mlNasal metered spray | A390211A39/16.1/0211Approved 27 September 2021 | Registered | Not determined | PIPIL |
| Nazene adult nasal drops EACH 1,0 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,500 mg | Drops | A390225A39/16.1/0225 | Cancelled | Not determined | None |
| Allergex eye drops EACH 1 ml CONTAINS :OXYMETAZOLINE HYDROCHLORIDE A 0,25 mg | Drops | H1274 | Old Medicine | Not determined | None |
| Sinustop nasal spray EACH 1 ml SOLUTION CONTAINS OXYMETAZOLINE HYDROCHLORIDE 0,5 mg | Spray | Y0251Y/16.1/251 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S2: Oxymetazoline
- except when intended for nasal use
Consolidated Schedules 06 July 2026, line 2476
S1: Oxymetazoline
- when intended for nasal use.
Consolidated Schedules 06 July 2026, line 952
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
Drag to rotate. Structure from PubChem CID 4636.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.